Stratégie thérapeutique non conventionnelle pour le contrôle des valeurs de la pression artérielle chez les hypertendus

2010 High blood pressure. Global and regional overview; 2013. [Disponible sur : http://www.searo.who.int/entity/world_health_day/leaflet_burden_hbp_whd2013.pdf] Danaei, 2011, National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5,4 million participants, Lancet, 377, 568, 10.1016/S0140-6736(10)62036-3 Dorobantu, 2018, Perspectives on hypertension's prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III survey, J Hypertens, 36, 690, 10.1097/HJH.0000000000001572 Wolf-Maier, 2003, Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States, JAMA, 289, 2363, 10.1001/jama.289.18.2363 Wolf-Maier, 2004, Hypertension treatment and control in five European countries, Canada, and the United States, Hypertension, 43, 10, 10.1161/01.HYP.0000103630.72812.10 Whelton, 2018, J Am Coll Cardiol, 71, e127, 10.1016/j.jacc.2017.11.006 Williams, 2018, ESC/ESH guidelines for the management of arterial hypertension, Eur Heart J, 39, 3021, 10.1093/eurheartj/ehy339 Waeber, 2007, Antihypertensive therapy according to the ESH/ESC guidelines, Rev Med Suisse, 3, 2003 Sramek, 2002, 1 Kaplan, 1990, 57 Albert, 2006, Bioimpedance cardiography measurements of cardiac output and other cardiovascular parameters, Cri Care Nurs Clin North Am, 18, 195, 10.1016/j.ccell.2006.01.008 Dorobantu, 2016, New national epidemiological survey for the assessment of trend in hypertension's prevalence, treatment and control among the adult population of Romania: SEPHAR III – design and methodology, J Hypertens Res, 2, 143 Settergren, 1986, The calculation of left ventricular stroke work index, Acta Anaesthesiol Scand, 30, 450, 10.1111/j.1399-6576.1986.tb02451.x Tan, 2014, Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8), Inov Pharm, 5, 10.24926/iip.v5i3.347 Dorobantu, 2014, Hypertension prevalence and control in Romania at a seven-year interval. Comparison of SEPHAR I and II surveys, J Hypertens, 32, 39, 10.1097/01.hjh.0000434937.62412.24 Dorobantu, 2015, Objectives and methodology of Romanian SEPHAR II Survey. Project for comparing the prevalence and control of cardiovascular risk factors in two East-European Countries: Romania and Poland, Arch Med Sci, 11, 715, 10.5114/aoms.2015.53290 Viigimaa, 2013, Identification of the hemodynamic modulators and hemodynamic status in uncontrolled hypertensive patients, Blood Press, 22, 362, 10.3109/08037051.2013.782900 Fadl Elmula, 2014, Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension, Hypertension, 63, 991, 10.1161/HYPERTENSIONAHA.114.03246 Ferrario, 2010, Individualizing hypertension treatment with impedance cardiography: a meta-analysis of published trials, Ther Adv Cardiovasc Dis, 4, 5, 10.1177/1753944709348236